You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 10, 2025

Drugs in ATC Class B05CB


✉ Email this page to a colleague

« Back to Dashboard


Drugs in ATC Class: B05CB - Salt solutions

TradenameGeneric Name
AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER amino acids; calcium chloride; dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium chloride
AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER amino acids; calcium chloride; dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium chloride
AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER amino acids; calcium chloride; dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium chloride
AMINOSYN II 5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER amino acids; calcium chloride; dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium chloride
CLINIMIX E 2.75/10 SULFITE FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER amino acids; calcium chloride; dextrose; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride
CLINIMIX E 2.75/25 SULFITE FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER amino acids; calcium chloride; dextrose; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride
PROCALAMINE amino acids; calcium acetate; glycerin; magnesium acetate; phosphoric acid; potassium chloride; sodium acetate; sodium chloride
>Tradename>Generic Name
Showing 1 to 7 of 7 entries

B05CB Market Analysis and Financial Projection

The market dynamics and patent landscape for ATC Class B05CB (Salt Solutions) reflect a sector driven by healthcare demands, innovation in medical formulations, and strategic intellectual property (IP) management. Here's a detailed analysis:


Market Dynamics

Growth Drivers

  • Surgical and Clinical Demand: Sodium chloride irrigation solutions, a key component of B05CB, are projected to grow from USD 1.5 billion (2022) to USD 2.5 billion by 2030 (CAGR 7.0%), driven by rising surgical volumes and chronic disease prevalence[11][14].
  • Aging Population: Increased hospitalization and surgical needs among elderly populations are amplifying demand[11].
  • Industrial and Healthcare Expansion: The global salt market is booming, with a forecasted rise from $45.74 billion (2024) to $68.06 billion by 2029, driven by food processing, mining, and medical applications[9][12].

Challenges

  • Regulatory Hurdles: Strict manufacturing standards and compliance requirements slow market entry[11][14].
  • Supply Chain Vulnerabilities: Raw material shortages and logistics disruptions impact production costs[9][14].

Opportunities

  • Emerging Markets: Asia-Pacific and Latin America offer untapped potential due to expanding healthcare infrastructure[11][14].
  • Innovative Formulations: Smart saline solutions and eco-friendly packaging are emerging trends in irrigation products[11][14].

Patent Landscape

Key Innovations

  • Crystal Morphology: Patents like US10881123B2 focus on salt crystal engineering to enhance perceived saltiness, reducing sodium content in medical and food products[17].
  • Production Methods: Techniques for efficient salt crystallization (e.g., US8888867) and recycling brine in manufacturing processes[18].
  • Drug Formulations: Sodium bicarbonate (B05CB04) and sodium citrate (B05CB02) dominate IP activity, with applications in metabolic acidosis treatment and anticoagulation[1][6][8].

Competitive IP Strategies

  • Market Leaders: Companies like Hospira, Baxter, and Fresenius hold multiple NDAs and Drug Master Files for intravenous and irrigating salt solutions[1][6][11].
  • Technology Segmentation: Patent filings emphasize trench MOSFETs in semiconductor packaging and sustainable production methods, though these intersect indirectly with medical salt solutions[13][16].

Trends

  • Strategic Filings: Accelerated patenting in combination therapies (e.g., sodium bicarbonate with psycholeptics) and sterile saline solutions[4][8].
  • Global IP Expansion: Companies prioritize filings in the U.S., China, and Europe to protect market share[10][13].

Key Players and Products

Company Product Application Key Patent/NDA
Hospira Sodium Bicarbonate Injection Metabolic acidosis treatment NDA 077394-001[1]
Baxter 0.45% Sodium Chloride Hydration and renal function assessment DrugBank DB09153[5][14]
Fresenius Bibag Irrigation Solution Dialysis and surgical irrigation EU Patent EP3090766B1[6]

Future Outlook

  • Technological Integration: Advances in smart irrigation systems and biodegradable packaging will shape the next decade[11][14].
  • Regulatory Collaboration: Harmonizing global standards (e.g., FDA, WHO) could streamline market access[12][16].

"The growth of salt solutions in healthcare underscores their critical role in surgical outcomes and chronic disease management." – Industry Report[14].

This sector’s growth hinges on balancing innovation with regulatory compliance, while IP strategies will focus on safeguarding novel formulations and production efficiencies.

References

  1. https://www.drugpatentwatch.com/p/generic-api/SODIUM+BICARBONATE
  2. https://atcddd.fhi.no/filearchive/publications/2025_guidelines__final_web.pdf
  3. https://atcddd.fhi.no/atc_ddd_index/?code=b05cb01
  4. https://atcddd.fhi.no/atc_ddd_index/?code=B05CB&showdescription=yes
  5. https://www.pharmacompass.com/chemistry-chemical-name/sodium-chloride-usp-crystal-grade
  6. https://go.drugbank.com/drugs/DB01390
  7. https://pubchem.ncbi.nlm.nih.gov/compound/Sodium-Bicarbonate
  8. https://go.drugbank.com/drugs/DB09154
  9. https://www.thebusinessresearchcompany.com/report/salt-global-market-report
  10. https://www.knowmade.com/patent-analytics-services/patent-report/semiconductor-patent-landscape/semiconductor-advanced-packaging-patent-landscape/hybrid-bonding-patent-landscape-analysis-2024/
  11. https://sites.google.com/view/innova-research/home/reports/sodium-chloride-irrigation-solution-market-analysis-current-landscape-and
  12. https://www.businesswire.com/news/home/20250321110344/en/United-States-Salt-Industry-Report-2025-Market-Review-2019-2024-and-Forecasts-2025-2029---SupplyDemand-Trade-Statistics-Production-Consumption---ResearchAndMarkets.com
  13. https://www.knowmade.com/patent-analytics-services/patent-report/semiconductor-patent-landscape/power-electronics-devices-patent-landscape/silicon-carbide-sic-patent-landscape-analysis-2024/
  14. https://www.verifiedmarketreports.com/product/sodium-chloride-irrigation-solution-market/
  15. https://www.acclaimip.com/patent-landscaping/patent-landscape-analysis-uncovering-strategic-insights/
  16. https://ip.com/blog/2025-patent-trends-challenges-and-innovations-shaping-the-future-of-technology/
  17. https://patents.google.com/patent/US10881123B2/en
  18. https://patents.justia.com/patents-by-us-classification/23/303

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.